Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies

Journal of biological regulators and homeostatic agents

Volumn 34, Issue 2, 2020, Pages 327-331

  Conti, P ^a   Ronconi, G ^b   Caraffa, A ^c   Gallenga, C ^d   Ross, R ^e   Frydas, I ^f   Kritas, S ^g  

^a UNIVERSITY OF CHIETI   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF CAMERINO   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^f ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^g ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

COVI 19; COVID 19; IL 1; IL 6; pro inflammatory cytokines; SARS CoV 2

Indexed keywords

ANTIINFLAMMATORY AGENT; IL-38 PROTEIN, HUMAN; IL37 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE;

BETACORONAVIRUS; CORONAVIRUS INFECTION; HUMAN; IMMUNOLOGY; PANDEMIC; VIRUS PNEUMONIA;

ANTI-INFLAMMATORY AGENTS; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKINS; PANDEMICS; PNEUMONIA, VIRAL;

EID: 85082948178     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: 10.23812/CONTI-E     Document Type: Editorial

References (0)